St. Jude Would Complete DES/CRT Trinity; Does Conor Need IP Absolution?
This article was originally published in The Gray Sheet
Executive SummaryConor Medsystems may realize a legal benefit from Boston Scientific's newly acquired right to sublicense the use of paclitaxel on coronary stents
You may also be interested in...
HAL Allergy Group, developer of products for allergy diagnostics and allergen immunotherapy, promoted its principal scientist to chief R&D officer; Starkey Hearing Technologies brought on new health and business development execs to expand its global footprint; and more.